Source comparison
Semax Versus Its Own Origin: A Structured Comparison
Because the title foregrounds “ACTH-related pathways,” the most illuminating comparison is between Semax and the ACTH biology it was carved from. Placing them side by side clarifies exactly which pathways Semax keeps, discards, or modifies — and where the resi
This comparison does not assign a generated winner or score.
- Because the title foregrounds “ACTH-related pathways,” the most illuminating comparison is between Semax and the ACTH biology it was carved from. Placing them side by side clarifies exactly which pathways Semax keeps, discards, or modifies — and where the resilience claim can and cannot lean on the ACTH heritage.
- Primary classical role
- Stimulates adrenal cortisol release
- Behavioral/neuromodulatory; minimal steroidogenic2
- Neuromodulatory only; no adrenal drive by design1
- Cortisol / HPA activation
- Yes (defining action)
- Largely absent
- Absent (the discarded arm)
- Metabolic stability
- Regulated hormone
- Rapidly degraded by peptidases
- Stabilized by C-terminal Pro-Gly-Pro4
- Melanocortin-receptor action
- Agonist across MC subtypes
- Weak/partial; some antagonism3
- Ambiguous; not a proven MC agonist3
- BDNF / neurotrophin effect
- Present within broader hormone action
- Retained behavioral effects
- ↑ BDNF/NGF, trkB activation (best-characterized)14
- Delivery for CNS effect
- Systemic hormone
- Experimental
- Intranasal, brain-directed
- Regulatory status
- Endogenous hormone / diagnostic use
- Research fragment
- Registered in Russia; not FDA/EMA approved
- The table makes the design logic vivid. Semax is ACTH with the hormonal engine removed, the neuromodulatory core preserved, the molecule stabilized for duration, and delivery re-routed to the brain. Every column labeled “absent by design” is a deliberate subtraction, and every column labeled “retained” or “best-characterized” is what the resilience hypothesis actually rests on. Critically, the melanocortin-receptor row is the one most often overstated: the compound’s heritage is melanocortin, but its receptor pharmacology is not the clean agonism the family name implies. This is why the most defensible mechanistic account leans on neurotrophic and anti-inflammatory gene programs rather than on a simple “Semax activates MC4R” narrative. For readers building vocabulary around these distinctions, the site’s peptide research glossary defines terms like melanocortin, neurotrophin, and trkB in a reference format.